The global medical aesthetic market is constantly expanding.
Increase in life expectancy and the rising importance of physical appearance over time, leads to an increase in demand for aesthetics and beauty treatments.
The hot and dry Israeli climate, combined with high smoking rates accelerates skin aging.
Patients demand fast & effective treatments, with minimum downtime, minimal pain, maximal results and proven safety records.
The local B2B Market
- Over 6,000 beauticians operate in Israel in various facilities
- 7 beauty academies operate nationwide
- 10 large chains specializing in beauty treatments operate nationwide
- There are 12 private hospitals and 21 state funded hospitals country wide.
- There are 150 active plastic surgeons of which 80 own and operate private clinics
- 150 Dermatologists operate nationwide
- Around 600 aestheticians operate nationwide
All of the above constitute a high sales and business potential
The local B2C Market
- Population: 8 million
- Female population: 51%
- 40 – 60 yr. old age percentile: 20%
- Plastic surgeries performed per year: ~ 20K
- Top selling treatments:
- Anti-aging treatments
- Skin rejuvenation
- Sun damage
- Hair removal
- Plastic surgeries (face & body)
- Top reasons to operate in Israel
Israel enjoys the sixth highest life expectancy in the world.
Further more, while life expectancy in the US grew by 4 years since 1980, and on the whole in OECD countries by 6 years, life expectancy in Israel has increased by 7 years within the specified time frame.
Superior Medical Care
Israeli longevity is largely a result of the country's top quality healthcare system –considered one of the best in the world. The national and private healthcare systems are constantly on the lookout for new products which can advance and improve the health of the population.
As great admirers and early adapters of innovation, Israelis are frequently willing to try out new products. The high value Israelis place on innovation is evident in that Israel is among the top five countries in the world when it comes to patents per capita, and in recent years it was in the top of the list for patents per capita for medical devices. Altogether, there are an estimated 1,000 life science companies in Israel, with approximately 70 new startups emerging every year.
Israel is also the world leader in R&D as a percentage of gross domestic product, with roughly 4.5% of Israeli GDP devoted to R&D. By contrast, the United States comes in at about 2.5%.
Nova Medical Business Strategy
To lead technological innovations
To provide customers with a full “One Stop Shop”
To provide various financial models to assist customers in advancing their business
Credit risk management
The One Stop Shop:
The company provides its B2B customers with an overall and complete professional package including:
Sale and distribution of equipment, accessories and expendables
Professional business assistance to enhance success levels
Marketing & sales support
Clinical & operational training
Full time clinical support
Financial solutions both through and outside the banking service
Maintenance and warranties for all equipment
Engines of Growth
Expansion of customer base to the B2C market
Revenue share option providing medical clinics with technological equipment for a percentage of revenues
Establishment of a chain of “innovative vaginal treatments” clinics nationwide and worldwide
Expansion of product range
Medical equipment (orthopedic, gynecological and aesthetic)
Aesthetic technologies and products (including creams, expendables, applications etc.)